Review article: Sleep-related gastro-oesophageal reflux as a distinct clinical entity

Alimentary Pharmacology and Therapeutics

Volumn 31, Issue 1, 2010, Pages 47-56

  Orr, W C ^a  

^a LYNN HEALTH SCIENCE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE;

ACID SECRETION; BARRETT ESOPHAGUS; BEDTIME DOSAGE; CIRCADIAN RHYTHM; CLINICAL FEATURE; DRUG ABSORPTION; DRUG EFFICACY; DRUG RELEASE; ESOPHAGITIS; ESOPHAGUS MUCOSA; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; INFORMATION PROCESSING; MORNING DOSAGE; PERCEPTION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PULMONARY ASPIRATION; RESPIRATORY TRACT DISEASE; REVIEW; SLEEP; SYMPTOM; WAKEFULNESS;

ESOPHAGEAL PH MONITORING; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; HYDROGEN-ION CONCENTRATION; POLYSOMNOGRAPHY; PREVALENCE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 71449095839     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04124.x     Document Type: Review

References (48)

1. Freidin N, Fisher MJ, Taylor W, et al. Sleep and nocturnal acid reflux in normal subjects and patients with reflux oesophagitis. Gut 1991 32 : 1275 1279.
2. Farup C, Kleinman L, Sloan S, et al. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med 2001 161 : 45 52.
3. Kahrilas PJ, Pandolfino JE. Gastroesophageal reflux disease and its complications, including Barrett's metaplasia. In : Feldman M, Friedman LS, Sleisenger MH, eds. Sleisenger and Fordtran Gastrointestinal and Liver Disease, 7th edn. Philadelphia : W.B. Saunders, 2002 : 599 622.
4. Locke GR III., Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterol 1997 112 : 1448 1456.
5. Shaker R, Castell DO, Schoenfeld PS, Spechler SJ. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol 2003 98 : 1487 1493.
6. Dent J, Dodds WJ, Friedman RH, et al. Mechanism of gasroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest 1980 65 : 256 267.
7. Penzel T, Becker HR, Brandenburg U, Labunski T, Pankow W, Peter JH. Arousal in patients with gastro-esophageal reflux and sleep apnoea. Eur Respir J 1999 14 : 1266.
8. DeMeester TR, Johnson LF, Joseph GJ, Toscano MS, Hall AW, Skinner DB. Patterns of gastroesophageal reflux in health and disease. Ann Surg 1976 187 : 459 470.
9. Campos GM, Peters JH, DeMeester TR, Oberg S, Crookes PF, Mason RJ. The pattern of esophageal acid exposure in gastroesophageal reflux disease influences the severity of the disease. Arch Surg 1999 134 : 882 888.
10. Richter JE, Bradley LA, DeMeester TR, Wu WC. Normal 24-hr ambulatory esophageal pH values: influence of study center, pH electrode, age, and gender. Dig Dis Sci 1992 6 : 849 856.
11. Dickman R, Shapiro M, Malagon IB, Powers J, Fass R. Assessment of 24 hr. oesphageal pH monitoring should be divided to awake and asleep rather than upright and supine time periods. Neurogastroenterol Motil 2007 19 : 709 715.
12. Orr WC, Goodrich S, Fernstrom P, Hasselgren G. Occurnce of night time gastroesophageal reflux in disturbed and normal sleepers. Clin. Gastro. Hep 2008 10 : 1099 1104.
13. Douglas NJ. Respiratory physiology: control of ventilation. Principles & Practice of Sleep Medicine, 4th edn., Elsevier, Philadelphia, PA. 2005 : 224 231.
14. Verrier RL, Harper RM, Jobson JA. Cardiovascular physiology: central and autonomic regulation. Principles & Practice of Sleep Medicine, 4th edn., Elsevier, Philadelphia, PA. 2005 : 192 202.
15. Cauter EV. Endocrine Physiology. Principles & Practice of Sleep Medicine, 4th edn., Elsevier, Philadelphia, PA. 2005 : 266 282.
16. Orr W. Sleep and gastroesophageal reflux disease: a wake up call. Rev Gastroenterol Disord 2004 4 : S25 32.
17. Orr WC, Johnson LF, Robinson MG. Effect of sleep on swallowing, esophageal peristalsis, and acid clearance. Gastroenterology 1984 86 : 814 819.
18. Orr WC, Robinson MG, Johnson LF. Acid clearing during sleep in the pathogenesis of reflux esophagitis. Dig Dis Sci 1981 26 : 423.
19. Johnson LF, Harmon JW. Experimental esophagitis in a rabbit model: clinical relevance. F Clin Gastroenterol 1986 8 : 26 44.
20. Gardner J, Rodriquez-Stanley S, Robinson M. Integrated acidity and the pathophysiology of gastroesophagel reflux disease. Amer J Gastro 2001 96 : 1363 1370.
21. Balow WJ, Orlando RC. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gastroenterology 2005 128 : 771 778.
22. Caviglia R, Ribolsi M, Maggiano N, et al. Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure. Amer J Gastroenterol 2005 100 : 543 548.
23. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Eng J Med 1999 340 : 825 831.
24. Orr WC, Lackey C, Robinson MG, Johnson LF, Welsh JD. Esophageal acid clearance during sleep in patients with Barrett's esophagus. Dig Dis Sci 1988 33 : 654 659
25. Orr WC, Allen ML, Robinson M. The pattern of nocturnal and diurnal esophageal acid exposure in the pathogenesis of erosive mucosal damage. Am J Gastroenterol 1994 89 : 509 512.
26. Dhiman RK, Saraswat VA, Mishra A, Naik SR. Inclusion of supine period in short-duration pH monitoring is essential in diagnosis of gastroesophageal reflux disease. Dig Dis Sci 1996 41 : 764 772.
27. Frazzoni M, De Micheli E, Savarino V. Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non-erosive reflux disease. Aliment Pharmacol Ther 2003 18 : 1091 1098.
28. Dubois RW, Aguilar D, Fass R, et al. Consequences of frequent nocturnal gastroesophageal reflux disease among employed adults: symptom severity, quality of life, and work productivity. Aliment Pharmacol Ther 2007 25 : 487 500.
29. Dean BB, Aguilar D, Johnson LF, et al. Nighttime and daytime atypical manifestations of gastroesophageal reflux disease: frequency, severity, and impact on health-related quality of life. Aliment Pharmacol Ther 2008 27 : 327 337.
30. Orr WC, Johnson LF. Responses to difference levels of esophageal acidification during waking and sleep. Dig Dis Sci 1998 43 : 241 245.
31. Orr WC, Robinson MG, Johnson LF. The effect of esophageal acid volume on arousals from sleep and acid clearance. Chest 1991 99 : 251 355.
32. Orr WC, Elsenbruch S, Harnish MJ, Johnson LF. Proximal migration of esophageal acid perfusions during walking and sleep. Am J Gastroenterol 2000 98 : 37 42.
33. Orr WC, Craddock A, Goodrich S. Acidic and non-acidic reflux during sleep under conditions of powerful acid suppression. Chest 2007 131 : 460 465.
34. Cicala M, Emerenziani S, Caviglia R. Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003 18 : 605 613.
35. Weusten BL, Akkermans LM, van Berge-Henegouwen GP, Smout AJ. Symptom perception in gastroesophageal reflux disease is dependent on spatiotemporal reflux characteristics. Gastroenterol 1995 108 : 1739 1744.
36. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002 123 : 461 467. (Pubitemid 34827190)
37. Rex D, Cummings CW, Shaw M, et al. Screening for Barrett's in colonoscopy patienst with and without heartburn. Gastroenterology 2003 125 : 1670 1677.
38. Howden CW. Review article: pharmacological approaches to the optimal control of nocturnal intragastric acidity. Aliment Pharmacol Ther 2006 3 : 39 45.
39. Orr WC, Goodrich S, Robert J. The effect of acid suppression on sleep patterns and sleep-related gastro-oesophageal reflux. Aliment Pharmacol Ther 2005 21 : 103 108.
40. Dimarino AJ Jr., Banwait KS, Eschinger E. The effect of gastro-oesophageal reflux and omeprazole on key sleep parameters. Aliment Pharmacol Ther 2005 22 : 324 329.
41. Johnson DA, Orr WC, Crawley JA, et al. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial. Am J Gastroenterol 2005 100 : 1914 1922.
42. Miner P Jr., Katz PO, Chen Y, Sostek M. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole and rabeprazole: a five way crossover study. Am J Gastroenterol 2003 98 : 2616 2620.
43. Ours TM, Fackler WK, Richter JE, Vaezi MF. Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. Am J Gastroenterol 2003 98 : 545 550.
44. Castell D. Review of immediate release omeprazole for the treatment of gastric acid-related disorders. Opin Pharmacother 2005 6 : 2501 2510.
45. Fass R, Pulliam G, Johnson C, Garewal HS, Sampliner RE. Symptom severity and oesophageal chemosensitivity to acid in older and young patients with gastro-oesophageal reflux. Age and Aging 2000 29 : 125 130.
46. Vakily M, Zhang W, Wu J, Atkinson SN, Mulford D. Pharmacokinetics and pharmacodynamics of a known active PPI with a novel Dual Delayed Release technology, dexlansoprazole MR: a combined analysis of randomized controlled clinical trials. Curr Med Res Opin 2009 25 : 627 638.
47. Lee RD, Vakily M, Mulford D, Wu J, Atkinson SN. The effect and timing of food on the pharmacodinetics and pharmacodynamics of dexlansoprazole MR, an novel Dual Release Formulation of a proton pump inhibitor: evidence for dosing flexibility Aliment. Pharmacol Ther 2009 29 : 824 833.
48. Metz DC, Howden CW, Perez MC, Larsen L, O'Neil J, Atkinson SN. Clinical trials: dexlansoprazole MR, a proton pump inhibitor with dual delayed release technology, effectively controls symptoms an prevents relapse in patients with healed erosive esophagitis. Aliment Pharmacol Ther 2009 29 : 742 754.